GP
Palmer-Lourenco, Gaby
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Interleukin‐18 Binding Protein (IL‐18BP) Deficiency Affects Lymphocyte Activation and IL‐18 Expression in a Mouse Model of Liver Inflammation | European Journal of Immunology | 2025 | 84 | 50 | |||
Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors | Cell communication and signaling | 2025 | 81 | 30 | |||
Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | 2024 | 115 | 35 | |||
Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | 2024 | 117 | 21 | |||
GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer model | Frontiers in immunology | 2024 | 161 | 46 | |||
Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | 2023 | 171 | 128 | |||
Editorial : Modulating cytokines as treatment for autoimmune diseases and cancer : volume II | Frontiers in immunology | 2023 | 90 | 144 | |||
IL-18 Binding Protein–Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome | The Journal of immunology | 2023 | 114 | 92 | |||
Cell Intrinsic IL-38 Affects B Cell Differentiation and Antibody Production | International journal of molecular sciences | 2023 | 112 | 97 | |||
Special Issue “IL-1 family cytokines in host defense, inflammation and cancer” | Cytokine | 2022 | 197 | 175 | |||
Arithmétique de la malbouffe | Revue médicale suisse | 2022 | 191 | 314 | |||
Editorial: Post-translational modifications of extracellular signaling molecules and antigens in immune and inflammatory responses | Frontiers in immunology | 2022 | 169 | 68 | |||
IL ‐38 orchestrates proliferation and differentiation in human keratinocytes | Experimental dermatology | 2022 | 261 | 179 | |||
Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytes | Gene | 2022 | 269 | 138 | |||
Multifaceted roles of IL-38 in inflammation and cancer | Cytokine | 2022 | 257 | 161 | |||
Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles | Journal of controlled release | 2022 | 377 | 310 | |||
IL-1 family antagonists in mouse and human skin inflammation | Frontiers in Immunology | 2021 | 363 | 146 | |||
Un équilibre à fleur de peau | Revue médicale suisse | 2021 | 240 | 127 | |||
IL-38 Ablation Reduces Local Inflammation and Disease Severity in Experimental Autoimmune Encephalomyelitis | Journal of Immunology | 2021 | 286 | 0 | |||
Intracellular IL-1 receptor antagonist isoform 1 released from keratinocytes upon cell death acts as an inhibitor for the alarmin IL-1α | Journal of Immunology | 2020 | 354 | 2 | |||
Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages | Immunity | 2020 | 453 | 210 | |||
Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome | Journal of Immunology | 2020 | 274 | 1 | |||
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | 2020 | 307 | 8 | |||
Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes | PLOS ONE | 2019 | 375 | 169 | |||
Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice | Blood | 2018 | 451 | 2 | |||
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression | PLOS ONE | 2018 | 508 | 239 | |||
IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro | Annals of the Rheumatic Diseases | 2017 | 422 | 0 | |||
Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses | Journal of Immunology | 2017 | 754 | 2 | |||
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease | Clinical and experimental immunology | 2016 | 538 | 2 | |||
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines | Cytokine | 2016 | 513 | 1 | |||
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells | Journal of Immunology | 2016 | 539 | 2 | |||
Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis | PLOS ONE | 2016 | 455 | 177 | |||
The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases | Cytokine | 2015 | 308 | 0 | |||
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection | PloS one | 2015 | 552 | 209 | |||
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling | Immunity, inflammation and disease | 2015 | 1,176 | 184 | |||
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice | The Journal of immunology | 2015 | 671 | 2 | |||
Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | 2014 | 666 | 0 | |||
The severity of experimental arthritis is independent of IL-36 receptor signaling | Arthritis research & therapy | 2013 | 622 | 236 | |||
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions | Journal of leukocyte biology | 2013 | 539 | 519 | |||
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis" | Joint bone spine | 2013 | 561 | 0 | |||
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | 2013 | 636 | 260 | |||
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages | Cytokine | 2013 | 624 | 1 | |||
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Joint bone spine | 2012 | 733 | 728 | |||
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis | European Journal of Immunology | 2012 | 614 | 3 | |||
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology | 2012 | 686 | 0 | |||
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells | Blood | 2012 | 870 | 958 | |||
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | 2012 | 660 | 0 | |||
Inhibition of osteoclast differentiation by the interleukin (IL)-1 family cytokine IL-33 | IBMS boneKEy | 2011 | 623 | 719 | |||
IL-36R ligands are potent regulators of dendritic and T cells | Blood | 2011 | 648 | 0 | |||
IL-33 biology with potential insights into human diseases | Nature reviews. Rheumatology | 2011 | 600 | 0 | |||
IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling | Cytokine | 2011 | 616 | 965 | |||
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | 2011 | 640 | 0 | |||
Expression and function of the NALP3 inflammasome in rheumatoid synovium | Immunology | 2010 | 552 | 0 | |||
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | The Journal of immunology | 2010 | 544 | 0 | |||
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist | Arthritis and rheumatism | 2010 | 610 | 0 | |||
IL-1 pathways in inflammation and human diseases | Nature reviews. Rheumatology | 2010 | 729 | 1 | |||
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | 2009 | 651 | 0 | |||
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice | Arthritis research & therapy | 2009 | 792 | 801 | |||
Mutations in the IL1RN locus lead to autoinflammation | Nature reviews. Rheumatology | 2009 | 574 | 0 | |||
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure | Joint bone spine | 2009 | 560 | 0 | |||
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory | The Journal of immunology | 2009 | 862 | 0 | |||
Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | 2009 | 664 | 492 | |||
IL-1, IL-18, and IL-33 families of cytokines | Immunological reviews | 2008 | 893 | 3,630 | |||
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 | Cytokine | 2008 | 695 | 0 | |||
Expression and function of junctional adhesion molecule-C in human and experimental arthritis | Arthritis research & therapy | 2007 | 640 | 335 | |||
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Cytokine | 2007 | 514 | 0 | |||
Leukocyte migration to rheumatoid joints: Enzymes take over | Arthritis and rheumatism | 2006 | 580 | 1 | |||
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes | Arthritis research & therapy | 2006 | 573 | 279 | |||
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Arthritis research & therapy | 2004 | 477 | 159 |